Dysregulation of GSK3β expression leads to many pathological conditions, including neuronal dysfunction, Alzheimer’s disease [130], and Parkinson’s disease [131]. The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.